S.05.05 Ibogaine therapy
European Neuropsychopharmacology January 1, 2005 Peer reviewed DOI: 10.1016/s0924-977x(05)80607-8 via OpenAlex
Abstract
No abstract available from the source.
Related reading
- Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Psychedelics. • October 28, 2025 • via OpenAlex
- Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta‐analyses of randomized controlled trials Psychiatry and Clinical Neurosciences Reports • December 1, 2024 • via OpenAlex
- Faculty Opinions recommendation of Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature • June 28, 2021 • via OpenAlex
- Novel treatment of opioid use disorder using ibogaine and iboga in two adults Journal of Evolutionary Psychology • March 30, 2020 • via OpenAlex
- The antiaddictive effects of ibogaine: A systematic literature review of human studies Journal of Psychedelic Studies • April 1, 2017 • via OpenAlex